ABN AMRO Investment Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.4M Buy
256,386
+84,336
+49% +$11.1M 0.28% 70
2026
Q1
$24M Sell
172,050
-5,599
-3% -$784K 0.31% 71
2025
Q4
$21.8M Buy
177,649
+128,716
+263% +$15.6M 0.32% 61
2025
Q3
$5.43M Buy
48,933
+1,135
+2% +$129K 0.11% 144
2025
Q2
$5.3M Sell
47,798
-532
-1% -$56.6K 0.11% 151
2025
Q1
$5.42M Buy
48,330
+13,266
+38% +$1.37M 0.11% 154
2024
Q4
$3.24M Buy
35,064
+390
+1% +$35.1K 0.06% 205
2024
Q3
$2.91M Sell
34,674
-574
-2% -$43.8K 0.05% 221
2024
Q2
$2.42M Sell
35,248
-302
-0.8% -$20.2K 0.04% 233
2024
Q1
$2.6M Sell
35,550
-907,191
-96% -$69.8M 0.05% 234
2023
Q4
$76.4M Buy
942,741
+14,006
+2% +$1.09M 1.34% 21
2023
Q3
$69.6M Sell
928,735
-2,192
-0.2% -$169K 1.36% 16
2023
Q2
$71.7M Buy
930,927
+1,569
+0.2% +$125K 1.44% 15
2023
Q1
$77.1M Buy
+929,358
New +$77M 1.59% 11

Other funds holding GILD

ABN AMRO Investment Solutions's GILD Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Gilead Sciences (GILD) stake by 49% in Q2 2026, buying an estimated $11.1M and bringing the position to 256,386 shares worth $32.4M. The position accounts for 0.28% of the portfolio, ranked #70.

ABN AMRO Investment Solutions first reported a position in GILD in Q1 2023 and has held it in 14 quarters since. The position peaked at $77.1M in Q1 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ABN AMRO Investment Solutions held 256,386 shares of Gilead Sciences worth $32.4M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 84,336 Gilead Sciences shares in Q2 2026, an estimated $11.1M.
  • Gilead Sciences made up 0.28% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #70 holding.
  • ABN AMRO Investment Solutions first reported a position in Gilead Sciences in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's Gilead Sciences position peaked at $77.1M in Q1 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.